3-10466811-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001001331.4(ATP2B2):​c.-319-16949A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.597 in 152,154 control chromosomes in the GnomAD database, including 27,866 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.60 ( 27866 hom., cov: 33)

Consequence

ATP2B2
NM_001001331.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0930

Publications

10 publications found
Variant links:
Genes affected
ATP2B2 (HGNC:815): (ATPase plasma membrane Ca2+ transporting 2) The protein encoded by this gene belongs to the family of P-type primary ion transport ATPases characterized by the formation of an aspartyl phosphate intermediate during the reaction cycle. These enzymes remove bivalent calcium ions from eukaryotic cells against very large concentration gradients and play a critical role in intracellular calcium homeostasis. The mammalian plasma membrane calcium ATPase isoforms are encoded by at least four separate genes and the diversity of these enzymes is further increased by alternative splicing of transcripts. The expression of different isoforms and splice variants is regulated in a developmental, tissue- and cell type-specific manner, suggesting that these pumps are functionally adapted to the physiological needs of particular cells and tissues. This gene encodes the plasma membrane calcium ATPase isoform 2. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
ATP2B2 Gene-Disease associations (from GenCC):
  • hearing loss, autosomal dominant 82
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • neurodevelopmental disorder
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.718 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP2B2NM_001001331.4 linkc.-319-16949A>G intron_variant Intron 1 of 22 ENST00000360273.7 NP_001001331.1 Q01814-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP2B2ENST00000360273.7 linkc.-319-16949A>G intron_variant Intron 1 of 22 5 NM_001001331.4 ENSP00000353414.2 Q01814-1

Frequencies

GnomAD3 genomes
AF:
0.597
AC:
90788
AN:
152036
Hom.:
27845
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.726
Gnomad AMI
AF:
0.553
Gnomad AMR
AF:
0.580
Gnomad ASJ
AF:
0.595
Gnomad EAS
AF:
0.730
Gnomad SAS
AF:
0.698
Gnomad FIN
AF:
0.558
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.513
Gnomad OTH
AF:
0.584
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.597
AC:
90852
AN:
152154
Hom.:
27866
Cov.:
33
AF XY:
0.602
AC XY:
44778
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.725
AC:
30077
AN:
41490
American (AMR)
AF:
0.580
AC:
8866
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.595
AC:
2064
AN:
3470
East Asian (EAS)
AF:
0.730
AC:
3786
AN:
5186
South Asian (SAS)
AF:
0.698
AC:
3367
AN:
4824
European-Finnish (FIN)
AF:
0.558
AC:
5906
AN:
10582
Middle Eastern (MID)
AF:
0.605
AC:
178
AN:
294
European-Non Finnish (NFE)
AF:
0.513
AC:
34863
AN:
67988
Other (OTH)
AF:
0.588
AC:
1242
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1832
3665
5497
7330
9162
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
760
1520
2280
3040
3800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.543
Hom.:
50330
Bravo
AF:
0.600
Asia WGS
AF:
0.725
AC:
2522
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.6
DANN
Benign
0.62
PhyloP100
-0.093
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34872; hg19: chr3-10508495; API